Key result
Pharmacist care interventions showed no significant effect on mortality, recurrent cardiac events, or hospitalizations in patients with coronary heart disease, but improved medication adherence and lipid management.
Why the study?
Does pharmacist care reduce mortality, cardiovascular events, and hospitalizations in patients with coronary heart disease?
Population
5 RCTs pooling 2,568 patients with coronary heart disease (CHD) in community and hospital settings.
Comparison
Pharmacist care interventions including patient… vs Usual care.
Design
Systematic_review
Follow-up
6 months to 2 years (across included studies)
Authors
Loading...
Does not reduce mortality, events, or hospitalizations in CHD; leaves open whether adherence gains improve outcomes in larger trials.
Systematic Review (n=2,568)
Does pharmacist care reduce mortality, cardiovascular events, and hospitalizations in patients with coronary heart disease?
Pharmacist care in patients with coronary heart disease improves medication adherence and risk factor control, though evidence for reducing mortality and cardiovascular events remains uncertain due to limited data.
Cai et al. (2013) conducted a systematic review in Coronary heart disease (n=2,568). Pharmacist care vs. Usual care was evaluated on Mortality, cardiovascular events, and hospitalizations. Pharmacist care interventions showed no significant effect on mortality, recurrent cardiac events, or hospitalizations in patients with coronary heart disease, but improved medication adherence and lipid management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: